HIGHMARK COMMERCIAL MEDICAL POLICY - PENNSYLVANIA

 
 

Medical Policy:
M-34-021
Topic:
Electroencephalogram (EEG) Technologies
Section:
Diagnostic Medical
Effective Date:
May 28, 2018
Issued Date:
September 17, 2018
Last Revision Date:
September 2018
Annual Review:
September 2018
 
 

An EEG is a recording of the electrical current potentials spontaneously from nerve cells in the brain onto the skull. Variations in wave characteristics correlate with neurological conditions and are used to diagnose conditions.

Policy Position Coverage is subject to the specific terms of the member's benefit plan.

Transmission of the EEG by telephone, radio, or cable may be considered medically necessary when the closest medical facilities are located in remote areas which lack trained EEG interpreters for individuals with the following indications:

  • Altered consciousness, such as stuporous, semi-comatose, or comatose states; or
  • Atypical seizure variants in individuals experiencing bizarre, distressing symptoms as seen with "spike and wave stupor" or other forms of seizure disorders; or
  • Head injury, where a subdural hematoma may be identified; or
  • Differentiation of complicated migraine with epilepsy-like symptoms (e.g., auras, alterations in level of consciousness) from true seizure disorders.

Radio and cable telemetry of the EEG may be considered medically necessary for:

  • EEG recording during provocation testing (e.g., withdrawal of anticonvulsant medications), which can be safely undertaken only in the immediate proximity of emergency medical personnel and technology; and
  • EEG recording attempting to localize the seizure focus’ prior to surgery when ambulation is desirable (e.g., when seizures are triggered by specific environmental stimuli or daily events).

95951

95956

 

 

 

 

 




Video EEG monitoring may be considered medically necessary for ANY ONE of the following indications and/or conditions:

  • The diagnosis cannot be made by neurological examination, standard EEG studies or ambulatory cassette EEG monitoring; or
  • Routine surface EEG is not diagnostic of a seizure disorder; or
  • Seizure activity is observed clinically but not captured by routine EEG; or
  • Seizure activity captured on routine EEG does not yield sufficient qualitative or quantitative data to determine a treatment regimen; or
  • Antiepileptic drug (AED) withdrawal is needed; or
  • Non-neurological causes of symptoms (e.g., syncope and cardiac arrhythmias) have been ruled out; or
  • To differentiate epileptic events from nonepileptic seizures such as psychogenic seizures; or
  • Individual with intractable epilepsy is being evaluated for surgical intervention; or
  • Seizure monitoring of a neonate or child is needed to develop or modify treatment; or
  • To monitor neonates with hypoxic-ischemic encephalopathy (HIE) who are being treated with therapeutic hypothermia (TH)

Note: Monitoring may be performed on an outpatient or inpatient basis, depending on the frequency and duration of seizure activity and length of time necessary to collect data. Individuals with frequent (at least three per week) intractable minor seizures and those individuals being evaluated for efficacy of drug treatment can be evaluated on an outpatient basis, in 3-12 hours. Inpatient monitoring is required for individuals such as those with seizures that only occur at night, are infrequent, are clinically severe (such as prolonged complex partial seizures), or are provoked by drug withdrawal.

Twenty-four hour ambulatory cassette-recorded EEGs may be medically necessary in the following circumstances:

  • When used in conjunction with ambulatory electrocardiogram (ECG) recordings for seizures suspected to be of cardiogenic origin; or
  • When used in conjunction with electro-oculogram (EOG) and electromyogram (EMG) recordings for suspected seizures of sleep disturbances; or
  • When used for quantification of seizures in patients who experience frequent absence seizures; or
  • When used in documenting seizures which are precipitated by naturally occurring cyclic events or environmental stimuli which are not reproducible in the hospital or clinic setting; or
  • To monitor neonates with HIE who are being treated with TH.

95951

99184

 

 

 

 

 




Quantitative electroencephalogram (QEEG) may be considered medically necessary when used as an adjunct to traditional EEG and/or diagnostic evaluation of epilepsy when ANY ONE of the following criteria is met:

  • The surface or long-term EEG is inconclusive and additional testing for possible epileptic spikes or seizures is needed; or
  • Ambulatory recording is needed to facilitate subsequent visual EEG interpretation; or
  • There is need for topographic voltage and dipole analysis in pre-surgical candidates with intractable epilepsy:
    • As continuous monitoring in the operating room for the early detection of an acute intracranial complication during cerebrovascular surgery (i.e., intracranial, carotid endarterectomy); or
    • As monitoring for the detection of nonconvulsive seizures in high risk individuals in the intensive care unit and operating room.

95955

95956

 

 

 

 

 




Digital analysis of electroencephalogram (DEEG) is considered not medically necessary as there is no evidence that such additional processing and interpretation has been shown to improve outcomes in individual management.

95957




Twenty-four hour ambulatory cassette-recorded EEGs are considered experimental/investigational and, therefore non-covered in the following circumstances:

  • For the study of neonates or unattended, uncooperative individuals; and
  • In localization of seizure focus/foci when the seizure symptoms and/or other EEG recordings indicate the presence of bilateral foci or rapid generalization; and
  • For final evaluation of individuals who are being considered as candidates for resective surgery.

Scientific evidence does not demonstrate the efficacy of twenty-four hour ambulatory cassette-recorded EEGs in certain instances.

Telephone transmission of the EEG to determine electrocerebral silence, i.e., brain death, is considered experimental/investigational, and therefore non-covered.

95824

95956

 

 

 

 

 




Quantitative electroencephalographic-based assessment (QEEG) is considered experimental/investigational and, therefore non-covered when used as a diagnostic aid for attention deficit/hyperactivity disorder.

95956




Covered Diagnosis Codes for Procedure Codes 95951, 95955,  95956, and 99184.

F10.11

F11.11

F11.23

F11.93

F12.11

F13.11

F13.230

F13.231

F13.232

F13.239

F13.930

F13.931

F13.932

F13.939

F14.11

F14.23

F15.11

F15.23

F15.93

F16.11

F17.203

F17.213

F17.223

F17.293

F18.11

F19.11

F19.230

F19.231

F19.232

F19.239

F19.930

F19.931

F19.932

F19.939

G40.001

G40.009

G40.011

G40.019

G40.101

G40.109

G40.111

G40.119

G40.201

G40.209

G40.211

G40.219

G40.301

G40.309

G40.311

G40.319

G40.401

G40.409

G40.411

G40.419

G40.501

G40.509

G40.801

G40.802

G40.803

G40.804

G40.811

G40.812

G40.813

G40.814

G40.821

G40.822

G40.823

G40.824

G40.89

G40.901

G40.909

G40.911

G40.919

G40.A01

G40.A09

G40.A11

G40.A19

G40.B01

G40.B09

G40.B11

G40.B19

G43.101

G43.109

G43.111

G43.119

G43.501

G43.509

G43.511

G43.519

G43.601

G43.609

G43.611

G43.619

P10.0

P90

R40.0

R40.1

R40.2110

R40.2111

R40.2112

R40.2113

R40.2114

R40.2120

R40.2121

R40.2122

R40.2123

R40.2124

R40.2130

R40.2131

R40.2132

R40.2133

R40.2134

R40.2140

R40.2141

R40.2142

R40.2143

R40.2144

R40.2210

R40.2211

R40.2212

R40.2213

R40.2214

R40.2220

R40.2221

R40.2222

R40.2223

R40.2224

R40.2230

R40.2231

R40.2232

R40.2233

R40.2234

R40.2240

R40.2241

R40.2242

R40.2243

R40.2244

R40.2250

R40.2251

R40.2252

R40.2253

R40.2254

R40.2310

R40.2311

R40.2312

R40.2313

R40.2314

R40.2320

R40.2321

R40.2322

R40.2323

R40.2324

R40.2330

R40.2331

R40.2332

R40.2333

R40.2334

R40.2340

R40.2341

R40.2342

R40.2343

R40.2344

R40.2350

R40.2351

R40.2352

R40.2353

R40.2354

R40.2360

R40.2361

R40.2362

R40.2363

R40.2364

R40.2410

R40.2411

R40.2412

R40.2413

R40.2414

R40.2420

R40.2421

R40.2422

R40.2423

R40.2424

R40.2430

R40.2431

R40.2432

R40.2433

R40.2434

R40.2440

R40.2441

R40.2442

R40.2443

R40.2444

R40.3

R40.4

R56.00

R56.01

R56.1

R56.9

S06.5X0A

S06.5X0D

S06.5X0S

S06.5X1A

S06.5X1D

S06.5X1S

S06.5X2A

S06.5X2D

S06.5X2S

S06.5X3A

S06.5X3D

S06.5X3S

S06.5X4A

S06.5X4D

S06.5X4S

S06.5X5A

S06.5X5D

S06.5X5S

S06.5X6A

S06.5X6D

S06.5X6S

S06.5X7A

S06.5X8A

S06.5X9A

S06.5X9D

S06.5X9S



Place of Service: Inpatient/Outpatient

Experimental/Investigational (E/I) services are not covered regardless of place of service.

The use of EEG Technologies is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.


The policy position applies to all commercial lines of business


Denial Statements

Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.

Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.



Links






This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical or other circumstances may warrant individual consideration, based on review of applicable medical records, as well as other regulatory, contractual and/or legal requirements.

Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
  • Qualified sign language interpreters
  • Written information in other formats (large print, audio, accessible electronic formats, other formats)

  • Provides free language services to people whose primary language is not English, such as:
  • Qualified interpreters
  • Information written in other languages
  • If you need these services, contact the Civil Rights Coordinator.

    If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

    You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

    U.S. Department of Health and Human Services
    200 Independence Avenue, SW
    Room 509F, HHH Building
    Washington, D.C. 20201
    1-800-368-1019, 800-537-7697 (TDD)

    Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

    Insurance or benefit/claims administration may be provided by Highmark, Highmark Choice Company, Highmark Coverage Advantage, Highmark Health Insurance Company, First Priority Life Insurance Company, First Priority Health, Highmark Benefits Group, Highmark Select Resources, Highmark Senior Solutions Company or Highmark Senior Health Company, all of which are independent licensees of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.





    Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

    Discrimination is Against the Law
    The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
  • Qualified sign language interpreters
  • Written information in other formats (large print, audio, accessible electronic formats, other formats)

  • Provides free language services to people whose primary language is not English, such as:
  • Qualified interpreters
  • Information written in other languages
  • If you need these services, contact the Civil Rights Coordinator.

    If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295 , TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

    You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

    U.S. Department of Health and Human Services
    200 Independence Avenue, SW
    Room 509F, HHH Building
    Washington, D.C. 20201
    1-800-368-1019, 800-537-7697 (TDD)

    Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.